bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.08.02.742271

Plant DNA Designer: A Computational Framework for Multi-Objective Codon Optimisation and Synthetic Gene Design in Crop Biotechnology

Abstract

Synthetic gene design for plant transformation requires simultaneous optimisation of multiple, often competing, molecular objectives: translational efficiency, mRNA structural accessibility, codon-pair compatibility, regulatory safety, and species-specific expression context. Existing tools address these objectives in isolation, typically maximising a single metric such as the Codon Adaptation Index (CAI) and neglecting the broader determinants of in-plant expression. We present Plant DNA Designer (PDD), a web-based platform that integrates a 19-objective genetic algorithm with expression-cassette co-design, clade-aware translation-initiation logic, ribosome-velocity trajectory shaping, CRISPR guide-RNA design, and multi-gene pathway balancing across 18 crop species spanning monocot and dicot clades -- each using its own measured codon-usage table from the Kazusa Codon Usage Database. We benchmark PDD against faithful reproductions of the published algorithms of five external tools (JCat/OPTIMIZER/ATGme, IDT, TISIGNER, a CAI+GC heuristic, and a random floor) across six validated rice effector proteins. PDD is the only strategy that holds every objective within acceptable bounds at once: it reduces transgene safety liabilities from 2.3-3.5 to 0.0, and cuts deviation from a 50 % GC synthesis target from 21.8 to 4.0 percentage points, while raising codon harmony from 0.42 to 0.77 -- at a deliberate, moderate cost in raw CAI (0.79 vs 1.00). Consistent with a fair comparison rather than a strawman, a dedicated single-objective tool (IDT) still outperforms PDD on its own axis (harmony 0.93). We anchor the two central proxies against real biology: on 456 real rice genes, CAI and the wobble-weighted tAI are significantly higher in highly-expressed ribosomal-protein genes than in the genomic background (Mann-Whitney p [≤] 10-; tAI AUC 0.75) and correlate at Spearman{rho} = 0.93. Beyond this expression-class anchor, the reported design metrics are in-silico proxies, not wet-lab yield measurements. PDD is released as open-source software under an MIT licence and is freely accessible as a FastAPI web application.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

k, D., H, S.. 2026-08-06. Plant DNA Designer: A Computational Framework for Multi-Objective Codon Optimisation and Synthetic Gene Design in Crop Biotechnology. https://doi.org/10.64898/2026.08.02.742271

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗